Global Market Research Reports

  Overview and Scope Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).   Sizing and Forecast The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%.   The   growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure.   The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to $21.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%.   The growth in the forecast period can be attributed to personalized medicine,...

  The Cardiac Biomarkers Testing by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).   Learn More On The Cardiac Biomarkers Testing Market: https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report   According to The Business Research Company’s Cardiac Biomarkers Testing, The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%.   The   growth in the historic period can be attributed to increasing incidence of cardiovascular dis...